Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment

OBJECTIVE: We aimed to investigate the ability of natalizumab (NTZ)-treated patients to assume treatment-associated risks and the factors involved in such risk acceptance. METHODS: From a total of 185 patients, 114 patients on NTZ as of July 2011 carried out a comprehensive survey. We obtained disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Tur, Carmen, Tintoré, Mar, Vidal-Jordana, Ángela, Bichuetti, Denis, Nieto González, Pablo, Arévalo, María Jesús, Arrambide, Georgina, Anglada, Elisenda, Galán, Ingrid, Castilló, Joaquín, Nos, Carlos, Río, Jordi, Martín, María Isabel, Comabella, Manuel, Sastre-Garriga, Jaume, Montalban, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858305/
https://www.ncbi.nlm.nih.gov/pubmed/24340060
http://dx.doi.org/10.1371/journal.pone.0082796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858305/
https://www.ncbi.nlm.nih.gov/pubmed/24340060
http://dx.doi.org/10.1371/journal.pone.0082796

Ejemplares similares